These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 29086761)
21. Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues. Marinaccio A; Binazzi A; Bonafede M; Corfiati M; Di Marzio D; Scarselli A; Verardo M; Mirabelli D; Gennaro V; Mensi C; Schallemberg G; Merler E; Negro C; Romanelli A; Chellini E; Silvestri S; Cocchioni M; Pascucci C; Stracci F; Ascoli V; Trafficante L; Angelillo I; Musti M; Cavone D; Cauzillo G; Tallarigo F; Tumino R; Melis M; Occup Environ Med; 2015 Sep; 72(9):648-55. PubMed ID: 26045315 [TBL] [Abstract][Full Text] [Related]
22. [Costs of occupational diseases and accidents at work in Poland]. Rydlewska-Liszkowska I Med Pr; 2006; 57(4):317-24. PubMed ID: 17133912 [TBL] [Abstract][Full Text] [Related]
23. Osteoporosis: Economic Burden of Disease in Italy. Marcellusi A; Rotundo MA; Nardone C; Sciattella P; Gazzillo S; Rossini M; Barbagallo M; Antenori A; Valle D; Mennini FS Clin Drug Investig; 2020 May; 40(5):449-458. PubMed ID: 32248346 [TBL] [Abstract][Full Text] [Related]
24. Residual fibre lung burden among patients with pleural mesothelioma who have been occupationally exposed to asbestos. Merler E; Somigliana A; Girardi P; Barbieri PG Occup Environ Med; 2017 Mar; 74(3):218-227. PubMed ID: 27821674 [TBL] [Abstract][Full Text] [Related]
25. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
26. [Pleural mesothelioma in a school teacher: asbestos exposure due to DAS paste]. Barbieri PG; Somigliana A; Girelli R; Lombardi S; Sarnico M; Silvestri S Med Lav; 2016 Mar; 107(2):141-7. PubMed ID: 27015029 [TBL] [Abstract][Full Text] [Related]
28. Medical costs of asbestos-related diseases in Spain between 2004 and 2011. García-Gómez M; Garrido RU; López RC; Menéndez-Navarro A Ind Health; 2017 Feb; 55(1):3-12. PubMed ID: 27334423 [TBL] [Abstract][Full Text] [Related]
29. [Mesothelioma in construction workers: risk estimate, lung content of asbestos fibres, claims for compensation for occupational disease in the Veneto Region mesothelioma register]. Merler E; Bressan V; Somigliana A; Med Lav; 2009; 100(2):120-32. PubMed ID: 19382522 [TBL] [Abstract][Full Text] [Related]
30. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe. Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G; Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831 [TBL] [Abstract][Full Text] [Related]
31. Compensation of pleural mesothelioma in France: data from the French National Mesothelioma Surveillance Programme. Chamming's S; Clin B; Brochard P; Astoul P; Ducamp S; Galateau-Salle F; Ilg AG; Goldberg M; Gramond C; Imbernon E; Rolland P; Pairon JC Am J Ind Med; 2013 Feb; 56(2):146-54. PubMed ID: 22911649 [TBL] [Abstract][Full Text] [Related]
32. Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland. Torkki P; Paajanen J; Kytö V; Laaksonen S; Räsänen J; Myllärniemi M; Ilonen I Thorac Cancer; 2021 Oct; 12(19):2594-2600. PubMed ID: 34519165 [TBL] [Abstract][Full Text] [Related]
33. An Analysis of the Social and Economic Costs of Breast Cancer in Italy. Mennini FS; Trabucco Aurilio M; Gazzillo S; Nardone C; Sciattella P; Marcellusi A; Migliorini R; Sciannamea V; Piccioni A; Bolcato M; Barni S Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501588 [TBL] [Abstract][Full Text] [Related]
34. [Health expenditures for cases of pleural mesothelioma]. Zocchetti C Med Lav; 2015 Sep; 106(5):361-73. PubMed ID: 26384262 [TBL] [Abstract][Full Text] [Related]
35. Medical costs of cancer attributable to work in the Basque Country (Spain) in 2008. García Gómez M; Castañeda López R; Urbanos Garrido R; López Menduiña P; Markowitz S Gac Sanit; 2013; 27(4):310-7. PubMed ID: 23454869 [TBL] [Abstract][Full Text] [Related]
36. [Direct health care costs of lung and bladder cancer attributable to work. Spain, 2008]. García Gómez M; Urbanos Garrido R; Castañeda López R; López Menduiña P Rev Esp Salud Publica; 2012; 86(2):127-38. PubMed ID: 22991056 [TBL] [Abstract][Full Text] [Related]
37. A guide to compensation for asbestos-related diseases. Britton MG; Hughes DT; Phillips TJ Br Med J (Clin Res Ed); 1981 Jun; 282(6282):2107-11. PubMed ID: 6454455 [No Abstract] [Full Text] [Related]
38. Indirect costs of diabetes and its impact on the public finance: the case of Poland. Torój A; Mela A Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563 [TBL] [Abstract][Full Text] [Related]
39. Familial malignant mesothelioma: a population-based study in central Italy (1980-2012). Ascoli V; Romeo E; Carnovale Scalzo C; Cozzi I; Ancona L; Cavariani F; Balestri A; Gasperini L; Forastiere F Cancer Epidemiol; 2014 Jun; 38(3):273-8. PubMed ID: 24684899 [TBL] [Abstract][Full Text] [Related]
40. Geographical patterns of mesothelioma incidence and asbestos exposure in Lombardy, Italy. Mensi C; De Matteis S; Catelan D; Dallari B; Riboldi L; Pesatori AC; Consonni D Med Lav; 2016 Sep; 107(5):340-355. PubMed ID: 27681566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]